These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 34486009)
21. Macromolecular bipill of gemcitabine and methotrexate facilitates tumor-specific dual drug therapy with higher benefit-to-risk ratio. Das M; Jain R; Agrawal AK; Thanki K; Jain S Bioconjug Chem; 2014 Mar; 25(3):501-9. PubMed ID: 24506698 [TBL] [Abstract][Full Text] [Related]
22. One-step preparation of reduction-responsive cross-linked gemcitabine prodrug micelles for intracellular drug delivery. Chen X; Teng W; Jin Q; Ji J Colloids Surf B Biointerfaces; 2019 Sep; 181():94-101. PubMed ID: 31125923 [TBL] [Abstract][Full Text] [Related]
23. Synthesis and antitumor activity of a heterodinucleotide of BVDU and gemcitabine. Cappellacci L; Franchetti P; Vita P; Petrelli R; Grifantini M Nucleosides Nucleotides Nucleic Acids; 2008 May; 27(5):460-8. PubMed ID: 18569785 [TBL] [Abstract][Full Text] [Related]
24. Enhanced anti-tumor efficiency of gemcitabine prodrug by FAPα-mediated activation. Sun J; Yang D; Cui SH; Zhang HT; Fu Y; Wang JC; Zhang Q Int J Pharm; 2019 Mar; 559():48-57. PubMed ID: 30677483 [TBL] [Abstract][Full Text] [Related]
25. Theranostic reduction-sensitive gemcitabine prodrug micelles for near-infrared imaging and pancreatic cancer therapy. Han H; Wang H; Chen Y; Li Z; Wang Y; Jin Q; Ji J Nanoscale; 2016 Jan; 8(1):283-91. PubMed ID: 26608864 [TBL] [Abstract][Full Text] [Related]
26. Polyisoprenoyl gemcitabine conjugates self assemble as nanoparticles, useful for cancer therapy. Maksimenko A; Mougin J; Mura S; Sliwinski E; Lepeltier E; Bourgaux C; Lepêtre S; Zouhiri F; Desmaële D; Couvreur P Cancer Lett; 2013 Jul; 334(2):346-53. PubMed ID: 22935679 [TBL] [Abstract][Full Text] [Related]
27. Synthesis of Gemcitabine-Threonine Amide Prodrug Effective on Pancreatic Cancer Cells with Improved Pharmacokinetic Properties. Hong S; Fang Z; Jung HY; Yoon JH; Hong SS; Maeng HJ Molecules; 2018 Oct; 23(10):. PubMed ID: 30314360 [TBL] [Abstract][Full Text] [Related]
29. Potential Development of Tumor-Targeted Oral Anti-Cancer Prodrugs: Amino Acid and Dipeptide Monoester Prodrugs of Gemcitabine. Tsume Y; Drelich AJ; Smith DE; Amidon GL Molecules; 2017 Aug; 22(8):. PubMed ID: 28796151 [TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, and evaluation of liver-specific gemcitabine prodrugs for potential treatment of hepatitis C virus infection and hepatocellular carcinoma. Stephenson AA; Cao S; Taggart DJ; Vyavahare VP; Suo Z Eur J Med Chem; 2021 Mar; 213():113135. PubMed ID: 33454548 [TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of gemcitabine and its amino acid ester prodrug following intravenous and oral administrations in mice. Thompson BR; Shi J; Zhu HJ; Smith DE Biochem Pharmacol; 2020 Oct; 180():114127. PubMed ID: 32603666 [TBL] [Abstract][Full Text] [Related]
32. Carrier-free Janus nano-prodrug based on camptothecin and gemcitabine: Reduction-triggered drug release and synergistic in vitro antiproliferative effect in multiple cancer cells. Xu Y; Huang Y; Zhang X; Lu W; Yu J; Liu S Int J Pharm; 2018 Oct; 550(1-2):45-56. PubMed ID: 30138703 [TBL] [Abstract][Full Text] [Related]
33. H-gemcitabine: a new gemcitabine prodrug for treating cancer. Dasari M; Acharya AP; Kim D; Lee S; Lee S; Rhea J; Molinaro R; Murthy N Bioconjug Chem; 2013 Jan; 24(1):4-8. PubMed ID: 23237198 [TBL] [Abstract][Full Text] [Related]
34. Characterization of Gemcitabine Loaded Polyhydroxybutyrate Coated Magnetic Nanoparticles for Targeted Drug Delivery. Parsian M; Mutlu P; Yalcin S; Gunduz U Anticancer Agents Med Chem; 2020; 20(10):1233-1240. PubMed ID: 32156242 [TBL] [Abstract][Full Text] [Related]
35. Interaction of an amphiphilic squalenoyl prodrug of gemcitabine with cellular membranes. Bildstein L; Pili B; Marsaud V; Wack S; Meneau F; Lepêtre-Mouelhi S; Desmaële D; Bourgaux C; Couvreur P; Dubernet C Eur J Pharm Biopharm; 2011 Nov; 79(3):612-20. PubMed ID: 21784150 [TBL] [Abstract][Full Text] [Related]
36. A Hydrogen Peroxide Activatable Gemcitabine Prodrug for the Selective Treatment of Pancreatic Ductal Adenocarcinoma. Matsushita K; Okuda T; Mori S; Konno M; Eguchi H; Asai A; Koseki J; Iwagami Y; Yamada D; Akita H; Asaoka T; Noda T; Kawamoto K; Gotoh K; Kobayashi S; Kasahara Y; Morihiro K; Satoh T; Doki Y; Mori M; Ishii H; Obika S ChemMedChem; 2019 Aug; 14(15):1384-1391. PubMed ID: 31207139 [TBL] [Abstract][Full Text] [Related]
37. Overcoming Cancer Cell Drug Resistance by a Folic Acid Targeted Polymeric Conjugate of Buthionine Sulfoximine. Cilurzo F; Cristiano MC; Da Pian M; Cianflone E; Quintieri L; Paolino D; Pasut G Anticancer Agents Med Chem; 2019; 19(12):1513-1522. PubMed ID: 31241440 [TBL] [Abstract][Full Text] [Related]
38. Magnetic Nanoliposomes as in Situ Microbubble Bombers for Multimodality Image-Guided Cancer Theranostics. Liu Y; Yang F; Yuan C; Li M; Wang T; Chen B; Jin J; Zhao P; Tong J; Luo S; Gu N ACS Nano; 2017 Feb; 11(2):1509-1519. PubMed ID: 28045496 [TBL] [Abstract][Full Text] [Related]
39. MGMT expression affects the gemcitabine resistance of pancreatic cancer cells. Shi Y; Wang Y; Qian J; Yan X; Han Y; Yao N; Ma J Life Sci; 2020 Oct; 259():118148. PubMed ID: 32721465 [TBL] [Abstract][Full Text] [Related]
40. Folate-mediated targeting of polymeric conjugates of gemcitabine. Cavallaro G; Licciardi M; Salmaso S; Caliceti P; Gaetano G Int J Pharm; 2006 Jan; 307(2):258-69. PubMed ID: 16298091 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]